Stock Report

Download full stock data and analysis for free Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Kinnate Biopharma Inc (KNTE) Key Ratios

Stock Card factsheet share-fund-plan-icon

$2.65

$0.00 (0.00%)

As on 03-Apr-2024 16:00EDT

Market cap

info icon

$125 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 42.61 41.55 -2.41 -211.11 -268.54
Net Profit 44.50 43.04 2.28 -247.97 -266.42
EPS 44.50 46.68 7.38 18.88 --
Book Value -- -- -33.25 -60.78 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-23Dec-22Dec-21
EBIT-Margin info ----------
Net Margin info -15,380.78-15,380.78---5,067.60-25,693.97
Return on equity info -41.9819.34-58.86-42.00-25.09
Return on Capital info -41.5119.63-57.75-41.68-25.09
Return on Assets info -36.14-30.21-49.80-35.32-23.30
Debt to Equity (x) info ----0.020.02--

Profitability

View Detailed Peer Comparison

ROCE

-57.75

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
-57.75
-41.68
-25.09
-18.86
241.51
Peer Median
--
--
--
--
--
ROE

-58.86

--

Profit after tax / Average Net worth * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
-58.86
-42.00
-25.09
-18.86
241.51
Peer Median
--
--
--
--
--
ROA

-49.80

--

Profit after tax / Average Total assets * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
-49.80
-35.32
-23.30
-14.82
-27.84
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
--
-5,067.60
-25,693.97
--
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

EBIT Growth

-0.41

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
-0.41
-31.53
-150.30
-199.71
-57.43
Peer Median
--
--
--
--
--
Net Profit Growth

1.20

--

Year on year growth in profit after tax

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
1.20
-27.52
-152.35
-197.11
-56.30
Peer Median
--
--
--
--
--
EPS Growth

0.08

--

Year on year growth in earnings per share

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
0.08
-0.28
0.60
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.02

--

Total debt / Net worth

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
0.02
0.02
--
--
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.01

--

(Short term borrowings / Net worth)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
0.01
0.00
--
--
--
Peer Median
--
--
--
--
--
Current Ratio

13.19

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
13.19
13.45
20.88
54.79
39.82
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
--
-52.68
-258.94
-146.94
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
--
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

1,143.06

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
1,143.06
1,849.83
10,523.95
10,772.67
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-0.99

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
-0.99
-2.35
-8.72
-7.86
--
Peer Median
--
--
--
--
--
Price / Book Value

0.70

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
0.70
1.20
2.44
0.71
--
Peer Median
--
--
--
--
--
EV/EBITDA

0.33

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Kinnate Biopharma Inc (KNTE)
0.33
-0.60
-6.23
3.30
--
Peer Median
--
--
--
--
--
loading...
loading...